MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE

被引:0
|
作者
Razanskaite, Violeta [2 ]
Michail, Stephanie [1 ]
Morgan, James [1 ]
Davies, Michael [1 ]
Storey, Daneil [1 ]
Watters, Christopher [3 ]
Penman, Douglas [3 ]
Swaminathan, Mira [4 ]
Sabine, Joseph [3 ]
Chapman, Adam [2 ]
Reilly, Ian [4 ]
Flanagan, Paul [3 ]
Bodger, Keith [2 ]
Subramanian, Sreedhar [1 ]
机构
[1] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[2] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
[3] Arrowe Pk Hosp, Upton, England
[4] Countess Chester Hosp, Chester, Cheshire, England
关键词
D O I
10.1136/gutjnl-2019-BSGAbstracts.190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PTH-131
引用
收藏
页码:A100 / A100
页数:1
相关论文
共 50 条
  • [1] Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study
    Townsend, T.
    Razanskaite, V.
    Michail, S.
    Morgan, J.
    Davies, M.
    Storey, D.
    Watters, C.
    Penman, D.
    Swaminathan, M.
    Sabine, J.
    Chapman, A.
    Vyas, A.
    Reilly, I.
    Flanagan, P.
    Bodger, K.
    Subramanian, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S408
  • [2] COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY
    Townsend, Tristan
    Razanskaite, Violeta
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Storey, Daniel
    Watters, Christopher
    Penman, Douglas
    Swaminathan, Mira
    Reilly, Ian
    Flanagan, Paul
    Subramanian, Sreedhar
    [J]. GUT, 2021, 70 : A127 - A127
  • [3] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Lewis, James D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica L.
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Long, Millie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
  • [4] Effectiveness of ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor: A multi-centre comparative study
    Alric, H.
    Amiot, A.
    Kirchgesner, J.
    Treton, X.
    Allez, M.
    Bouhnik, Y.
    Beaugerie, L.
    Carbonnel, F.
    Meyer, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S118 - S120
  • [5] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [6] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
    Sharip, Mohmmed Tauseef
    Nishad, Nilanga
    Pillay, Lushen
    Goordoyel, Nilkantsingh
    Goerge, Samuel
    Subramanian, Sreedhar
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [7] Effectiveness of ustekinumab in fistulising perianal Crohn's disease refractory or intolerant to anti-TNF
    Carpio, D.
    Calvino-Suarez, C.
    Martinez-Cadilla, J.
    Molina, G.
    Vazquez-Rey, M. T.
    Marti, E.
    Fernandez-Salgado, E.
    Acosta, M. Barreiro-de
    Hernandez, V.
    Echarri, A.
    Diz-Lois, M. T.
    Baz, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S419 - S420
  • [8] Anti-TNF induction and maintenance therapy for refractory Crohn's disease
    Hartnell, F. L.
    Radford-Smith, G.
    Jones, L.
    Sewell, K.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 62 - 62
  • [9] Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Broglio, Giacomo
    Liu, Eleanor
    Limdi, Jimmy K.
    Selinger, Christian
    Fiske, Joseph
    Razanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. INFLAMMATORY BOWEL DISEASES, 2024,
  • [10] Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn's disease
    Dussias, N.
    Rizzello, F.
    Calabrese, C.
    Passino, A. Sanna
    Melotti, L.
    Scaioli, E.
    Belluzzi, A.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S528 - S528